Insurance Medicine Summit 2017

15 - 17 Nov 2017

Location: Rüschlikon/Zurich, Switzerland

Day 1

 

Wednesday, 15 November 2017

12.00

Lunch buffet

13.00

ECG challenges: Learnings, discussions and case reviews
Chair: Monica Wilson, Chief Medical Officer, Swiss Re

16.30

End of course
Coffee break and networking

18.00

Welcome address and opening remarks
John Schoonbee, Global Chief Medical Officer, Swiss Re

18.05

Opening presentations

  • CRISPR: The new age of genome editing
    Martin Jinek, Assistant Professor, University of Zurich
  • Too much medicine and the great statin con
    Aseem Malhotra, Honorary Consultant Cardiologist, Lister Hospital Stevenage and ROC Private Clinic

19.15

Welcome dinner

This event may be photographed, filmed and/ or recorded. A summary of the event, pictures and/or a video of the event in which you may appear may be posted and made available on Swiss Re’s and the Swiss Re Institute's internal and external websites and in printed materials.

Day 2

 

Thursday, 16 November 2017

08.00

Coffee and networking

09.00

Welcome and introduction
John Schoonbee, Global Chief Medical Officer, Swiss Re

 

THEME I: The metabolic pandemic

09.10

The obesity epidemic
Zoë Harcombe, Author and Researcher

09.45

New paradigms of type 2 diabetes
Jason Fung, IDM Program Medical Director and Scientific Editor of the Journal of Insulin Resistance

10.20

Panel discussion on nutrition and diabetes
Moderator: John Schoonbee, Global Chief Medical Officer, Swiss Re

Panellists:
Jason Fung, IDM Program Medical Director and Scientific Editor of the Journal of Insulin Resistance Program
Zoë Harcombe, Author and Researcher
David Unwin, Fellow of the Royal College of General Practitioners (FRCGP), and Senior Partner of the Norwood Surgery
Kelvyn Young, Head L&H Partnerships, Swiss Re

11.00

Coffee break

 

 


THEME II: Lifestyle, risks and new technologies
Breakout sessions (repeated)

11.30

Session 1: Deep learning applications in medicine & insurance
Daniel Thyssen, L&H IT Business Partner EMEA, Swiss Re
Urs Widmer, Senior Life Guide Medical Officer, Swiss Re

Session 2: Predictive modelling developments in the US market
Brian Ivanovic, Manager & Senior Researcher Applied R&D, Swiss Re

Session 3: Smoking, e-cigarettes, reduced-risk products
John Schoonbee, Global Chief Medical Officer, Swiss Re

Session 4: Wearables & apps: Tracking health vitals
Kelvyn Young, Head L&H Partnerships, Swiss Re

12.00

Breakouts repeated - round 2

12.40

Lunch

 

THEME III: Cardiovascular diseases

14.00

The lipid debate: What's new?
Detloff Rump, Chief Underwriter Asia, Swiss Re

14.30

Cardiac tests in underwriting: What tests? Who? When? Why?
Duncan Dymond, Consultant Cardiologist in London

 

THEME IV: A new era in cancer diagnostics and therapies

15.00

Liquid biopsies and the future of cancer detection
Nicola Aceto, Group Leader Department of Biomedicine, Cancer Metastasis, University of Basel

15.30

Latest immune therapy approaches: BITE, CAR-T and checkpoint inhibitors
Ulf Petrausch, Immunologist and Oncologist, Oncology Centre Hirslanden

16.00

Coffee break

16.30

Panel discussion: How will liquid biopsy and new therapeutics affect product definitions and design
Moderator: Urs Widmer, Senior Life Guide Medical Officer, Swiss Re

Panellists:
Nicola Aceto, Group Leader Department of Biomedicine, Cancer Metastasis, University of Basel
Ulf Petrausch, Immunologist and Oncologist, Oncology Centre Hirslanden
Robert Rubens, Global Medical Consultant, Swiss Re

17.15

Closing remarks

17.20

Apero and networking

18.15

Dinner

This event may be photographed, filmed and/ or recorded. A summary of the event, pictures and/or a video of the event in which you may appear may be posted and made available on Swiss Re’s and the Swiss Re Institute's internal and external websites and in printed materials.

Day 3

 

Friday, 17 November 2017

08.00

Coffee and networking

08.30

Welcome and introduction
Hector Wong, Regional Chief Medical Officer Asia, Swiss Re

 

THEME V: Somatic and psychiatric disorders and how they affect claims

08.40

Somatoform disorders: Concepts, consequences and treatments
Per Fink, Head of Research and Chief Physician, The Research Clinic for Functional Disorders, Aarhus University Hospital

09.10

Case study in handling burn-out claims
Pia Cox, Medical Manager Health Care, AG Insurance

09.40

Q&A with Per Fink and Pia Cox
Moderator: Joyce Vink-Van Gils, Senior Medical Officer, Swiss Re

10.00

Coffee break

 

THEME VI: Changing risk landscape with ageing populations

10.30

Who are the ageing and who pays for them?
Domenico Savarese, Head L&H Products Strategy, Swiss Re

11.00

Underwriting older ages
Marianne Cumming, Global Head L&H Underwriting Solutions, Swiss Re

11.30

Latest insights into research and therapies of Alzheimer and other neurodegenerative diseases
Nicholas Wood, Galton Chair of Genetics, Professor of Clinical Neurology and Neurogenetics, and Neuroscience Programme Director 

12.00

Closing remarks
John Schoonbee, Global Chief Medical Officer, Swiss Re 

12.15

Optional buffet lunch

13.15

End

This event may be photographed, filmed and/or recorded. A summary of the event, pictures and/or a video of the event in which you may appear may be posted and made available on Swiss Re’s and the Swiss Re Institute's internal and external websites and in printed materials.

Gallery

Photos by: Fredi Lienhardt

About the event

Following the success of the Insurance Medicine Summits in 2012 and 2014, our 3rd Insurance Medicine Summit took place on 15 - 17 November 2017, at the Swiss Re Centre for Global Dialogue near Zurich. Chief Medical Officers, Chief L&H Underwriters and Claims Managers of global insurers discussed the latest medical trends and advances together with leading academics, clinicians and researchers.

At the conference, we explored a wide spectrum of the latest research and developments in insurance medicine. Amongst the topics addressed was the paradigm shift in type 2 diabetes, the latest trends in cancer diagnostics and therapies, the risks and needs for an ageing population as well as the impact of new technologies on product innovation.

The programme was being set up in collaboration with medical officers across different continents. It will provide a unique platform, providing participants with tangible and practical information of direct relevance to their daily work, as well as their companies' guidelines and products.

John Schoonbee
Global Chief Medical Officer
Swiss Reinsurance Company Ltd

Speakers